Document ID: chunk:federal_register_of_legislation:F2025L00215:schedule:1:p14
Version: federal_register_of_legislation:F2025L00215
Segment Type: schedule
Provision Reference: sch 1 (pt 14/51)
Character Range: 37640–41295

"C10162"
[94] Schedule 4, Part 1, omit entry for Circumstances Code "P10170"
[95] Schedule 4, Part 1, omit entry for Circumstances Code "C10171"
[96] Schedule 4, Part 1, omit entry for Circumstances Code "C10172"
[97] Schedule 4, Part 1, omit entry for Circumstances Code "C10198"
[98] Schedule 4, Part 1, omit entry for Circumstances Code "C10199"
[99] Schedule 4, Part 1, omit entry for Circumstances Code "C10953"
[100] Schedule 4, Part 1, omit entry for Circumstances Code "C10955"
[101] Schedule 4, Part 1, omit entry for Circumstances Code "C13034"
[102] Schedule 4, Part 1, omit entry for Circumstances Code "C13072"
[103] Schedule 4, Part 1, entry for Circumstances Code "C13336"
insert in alphabetical order in the column headed "Listed Drug": Faricimab
[104] Schedule 4, Part 1, entry for Circumstances Code "C13387"
insert in alphabetical order in the column headed "Listed Drug": Faricimab
[105] Schedule 4, Part 1, entry for Circumstances Code "C14238"
(a) insert in alphabetical order in the column headed "Listed Drug": Progesterone
(b) insert in alphabetical order in the column headed "Listed Drug": Progesterone and estradiol
[106] Schedule 4, Part 1, omit entry for Circumstances Code "C14587"
[107] Schedule 4, Part 1, omit entry for Circumstances Code "C14588"
[108] Schedule 4, Part 1, omit entry for Circumstances Code "C14631"
[109] Schedule 4, Part 1, omit entry for Circumstances Code "C15065"
[110] Schedule 4, Part 1, omit entry for Circumstances Code "C15110"
[111] Schedule 4, Part 1, omit entry for Circumstances Code "C15177"
[112] Schedule 4, Part 1, omit entry for Circumstances Code "C15201"
[113] Schedule 4, Part 1, omit entry for Circumstances Code "C15338"
[114] Schedule 4, Part 1, omit entry for Circumstances Code "C15369"
[115] Schedule 4, Part 1, omit entry for Circumstances Code "C15395"
[116] Schedule 4, Part 1, omit entry for Circumstances Code "C15410"
[117] Schedule 4, Part 1, omit entry for Circumstances Code "C15430"
[118] Schedule 4, Part 1, omit entry for Circumstances Code "C15443"
[119] Schedule 4, Part 1, entry for Circumstances Code "C15553"
insert in alphabetical order in the column headed "Listed Drug": Duloxetine
[120] Schedule 4, Part 1, entry for Circumstances Code "C15902"
insert in alphabetical order in the column headed "Listed Drug": Risankizumab
[121] Schedule 4, Part 1, entry for Circumstances Code "C15903"
insert in alphabetical order in the column headed "Listed Drug": Risankizumab
[122] Schedule 4, Part 1, after entry for Circumstances Code "C16290"
insert:
C16292  P16292  CN16292  Blinatumomab           Acute lymphoblastic leukaemia                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Compliance with Written Authority Required procedures
                                                Induction treatment
                                                The condition must be relapsed or refractory B-precursor cell ALL, with an Eastern Cooperative Oncology Group (ECOG) performance status of 2 or less; AND
                                                The condition must not be present in the central nervous system or testis; AND
                                                Patient